Clinical Trial Update: Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) [Phase 1]

View source ↗

Summary

Phase Ib study investigating alpelisib in combination with pembrolizumab in metastatic breast cancer or melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Melanoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Piqray (alpelisib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma (Skin Cancer), Breast Cancer | Phase 1 | Status: RECRUITING